New Key Statistics Module, Z-Score and F-Score
OTCPK:DCPXF Key Ratios
Market Cap $ M | 1.32 |
Enterprise Value $ M | 1.29 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.27 |
Price/Sales | 0.24 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -0.02 |
Beneish M-Score | -17.11 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.17 |
EV-to-EBITDA | -1.42 |
PEG | -- |
Shares Outstanding M | 3,991.10 |
Net Margin (%) | -701.19 |
Operating Margin % | -118.50 |
Pre-tax Margin (%) | -670.75 |
Quick Ratio | 1.24 |
Current Ratio | 1.26 |
ROA % (ttm) | -213.24 |
ROE % (ttm) | -309.29 |
ROIC % (ttm) | -34.66 |
Dividend Yield % | -- |
Altman Z-Score | -9.00 |
DCPXF Number of Guru Trades
DCPXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:DCPXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:DCPXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DanCann Pharma AS Insider Transactions
No Available Data
News about OTCPK:DCPXF
Total 0- 1